Kiora Pharmaceuticals, Inc. (KPRX)
USD 3.26
(-6.59%)
USD 3.26
(-6.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -9.55 Million | -10.42 Million | -10.88 Million | -7.31 Million | -8.15 Million | -10.84 Million |
| Net Income | -12.51 Million | -13.58 Million | -16.39 Million | -8.09 Million | -7.09 Million | -10.81 Million |
| Depreciation & Amortization | 62.42 Thousand | 41.6 Thousand | 45.29 Thousand | 33.39 Thousand | 213.93 Thousand | 38.48 Thousand |
| Deferred income taxes | 90.31 Thousand | -113.01 Thousand | -304.78 Thousand | 12.05 Thousand | 95.39 Thousand | 86.04 Thousand |
| Stock-based compensation | 754.94 Thousand | 462.45 Thousand | 842.47 Thousand | 723.85 Thousand | 852.23 Thousand | 875.28 Thousand |
| Change in working capital | -1.82 Million | 668.51 Thousand | -1.03 Million | -321.2 Thousand | -2.71 Million | -1.03 Million |
| Other non-cash items | 3.87 Million | 2.09 Million | 5.96 Million | 326.67 Thousand | 500 Thousand | 2.28 Million |
| Investing Cash Flow | 44.99 Thousand | 6375.00 | -157.02 Thousand | -244.43 Thousand | - | -270 Thousand |
| Investments in PPE | 1.00 | - | -63.86 Thousand | -133.79 Thousand | - | -270 Thousand |
| Acquisitions | - | 6375.00 | -93.15 Thousand | -110.64 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 6.38 | - | -113.72 | - | -250.00 |
| Financing Cash Flow | 5.96 Million | 8.62 Million | 17.79 Million | 4.99 Million | 3.92 Million | 11.3 Million |
| Debt repayment | - | - | -212.28 Thousand | -278.19 Thousand | -4715.00 | -9782.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -15.62 Thousand | - | - | -2614.00 | - |
| Common Stock Issuance | 6.46 Million | 8.63 Million | 18.75 Million | 5 Million | 1.77 Million | 10.1 Million |
| Other Financing Activities | -495 Thousand | 8.63 Million | -742.52 Thousand | 275.69 Thousand | 2.15 Million | 1.19 Million |
| Accounts receivables | -548.1 Thousand | -872.73 Thousand | -441.19 Thousand | -18.95 Thousand | 13.21 Thousand | -685.73 Thousand |
| Accounts payables | -808.01 Thousand | 782.46 Thousand | -310.66 Thousand | 136.69 Thousand | 146.63 Thousand | -642.43 Thousand |
| Inventory | - | 872.73 Thousand | 441.19 Thousand | 18.95 Thousand | -13.21 Thousand | - |
| Other working capital | -465.82 Thousand | -113.95 Thousand | -725.13 Thousand | -457.9 Thousand | -2.86 Million | -390.46 Thousand |
| Cash at beginning of period | 5.96 Million | 7.89 Million | 1.23 Million | 3.82 Million | 8.04 Million | 7.85 Million |
| Cash at end of period | 2.45 Million | 6.01 Million | 7.89 Million | 1.23 Million | 3.82 Million | 8.04 Million |
| Capital Expenditure | 1.00 | - | -63.86 Thousand | -133.79 Thousand | - | -270 Thousand |
| Effect of forex changes on cash | 36.02 Thousand | -85.03 Thousand | -81.5 Thousand | -26.93 Thousand | 5503.00 | 7915.00 |
| Net cash flow / Change in cash | -3.5 Million | -1.88 Million | 6.66 Million | -2.59 Million | -4.22 Million | 198.2 Thousand |
| Free Cash Flow | -9.55 Million | -10.42 Million | -10.95 Million | -7.45 Million | -8.15 Million | -11.11 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.22 Million | 13.45 Million | -2.26 Million | -12.51 Million | -5.76 Million | -2.61 Million |
| Depreciation & Amortization | 17.87 Thousand | 16.21 Thousand | 7935.00 | 62.42 Thousand | 11.3 Thousand | 22.47 Thousand |
| Deferred income taxes | - | - | 90.31 Thousand | 90.31 Thousand | 1.9 Million | - |
| Stock-based compensation | 149.79 Thousand | 175.44 Thousand | 182.34 Thousand | 754.94 Thousand | 264.86 Thousand | 171.79 Thousand |
| Change in working capital | -1.72 Million | -7813.00 | -606.83 Thousand | -1.82 Million | -483.11 Thousand | 856.78 Thousand |
| Other non-cash items | 1.93 Million | 81.51 Thousand | 13.5 Thousand | 3.87 Million | 1.54 Million | 177.84 Thousand |
| Investing Cash Flow | -21.22 Million | - | -236.00 | 44.99 Thousand | - | - |
| Investments in PPE | -51.28 Thousand | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -21.28 Million | - | - | - | - | - |
| Sales/Maturities of investments | 115.65 Thousand | - | - | - | - | - |
| Other Investing Activities | -21.17 Million | - | - | - | - | - |
| Financing Cash Flow | 250.52 Thousand | 15.24 Million | -486.42 Thousand | 5.96 Million | - | 5.93 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 1.19 Million | -1.19 Million | -804.74 | - | - | - |
| Common Stock Issuance | -940.66 Thousand | 16.43 Million | 8579.00 | 6.46 Million | -813.32 Thousand | 6.75 Million |
| Other Financing Activities | 250.52 Thousand | 15.24 Million | -495 Thousand | -495 Thousand | 813.32 Thousand | -813.32 Thousand |
| Accounts receivables | -1.64 Million | -10.81 Thousand | -529.11 Thousand | -548.1 Thousand | -575.17 Thousand | 888.46 Thousand |
| Accounts payables | -58.54 Thousand | 124.97 Thousand | 40.63 Thousand | -808.01 Thousand | 15.01 Thousand | -508.03 Thousand |
| Inventory | - | - | 1.56 Million | - | 575.17 Thousand | -888.46 Thousand |
| Other working capital | -27.14 Thousand | -121.97 Thousand | -118.35 Thousand | -465.82 Thousand | -498.12 Thousand | 1.36 Million |
| Cash at beginning of period | 31.27 Million | 2.45 Million | 5.4 Million | 5.96 Million | 7.95 Million | 3.43 Million |
| Cash at end of period | 6.57 Million | 31.27 Million | 2.45 Million | 2.45 Million | 5.4 Million | 7.95 Million |
| Capital Expenditure | -51.28 Thousand | - | - | - | - | - |
| Effect of forex changes on cash | 6979.00 | -51.02 Thousand | 122.18 Thousand | 36.02 Thousand | -30.17 Thousand | -28.84 Thousand |
| Net cash flow / Change in cash | -24.7 Million | 28.82 Million | -2.94 Million | -3.5 Million | -2.55 Million | 4.52 Million |
| Free Cash Flow | -3.78 Million | 13.62 Million | -2.58 Million | -9.55 Million | -2.52 Million | -1.38 Million |
N01
AIFS
FAIRCHEMOR
CBQK
MRU
GRDLY